Welcome to our dedicated page for NeueHealth SEC filings (Ticker: NEUE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The NEUE SEC filings archive provides access to the historical regulatory documents of NeueHealth, Inc., a value-driven healthcare company that was formerly listed on the New York Stock Exchange under the symbol NEUE. While it was a public company, NeueHealth filed periodic and current reports that described its operations, financial condition, risk factors, and significant corporate events. These filings complement the company’s earnings releases, which discuss revenue categories such as capitated revenue, ACO REACH revenue, and service revenue, and present key metrics related to value-based consumers and enablement services lives.
Among the notable documents in NeueHealth’s regulatory history are its Form 8-K filings detailing material events. For example, a Form 8-K filed on October 2, 2025 describes the completion of a merger in which NH Holdings Acquisition 2025, Inc. merged with and into NeueHealth, with NeueHealth surviving as a wholly owned subsidiary of NH Holdings 2025, Inc., an entity indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. The same filing explains the change in control, treatment of common stock and equity awards, and the company’s plans to seek deregistration of its securities and suspension of its reporting obligations.
Another key filing is the Form 25 (Notification of Removal from Listing and/or Registration) filed on October 2, 2025 by the New York Stock Exchange, identifying NeueHealth, Inc. as the issuer and specifying that its common stock is being removed from listing and registration on the exchange. Earlier Forms 8-K in 2024 and 2025 document the entry into the Agreement and Plan of Merger, extensions of the merger agreement’s outside date, and the announcement of quarterly financial results.
On Stock Titan’s filings page for NEUE, users can review these historical SEC documents to understand how NeueHealth described its value-driven, consumer-centric care model, its activities across ACA Marketplace, Medicare, and Medicaid, and the steps that led to its take-private transaction and delisting. AI-powered tools on the platform can help summarize lengthy filings, highlight sections on revenue structure, value-based arrangements, and corporate transactions, and surface references to items such as Form 8-K event disclosures and the Form 25 delisting notice.
NeueHealth filed a Registration Statement on Form S-8 (File No. 333-279463) on May 16, 2024 to register 2,275,000 shares of common stock, par value $0.0001, for issuance under the NeueHealth, Inc. Second Amended and Restated 2021 Omnibus Incentive Plan. The filing references a prior Form S-8 (File No. 333-257477) filed June 28, 2021 that registered 42,000,000 shares for the 2021 Incentive Plan and 72,285,567 shares for the Bright Health Group, Inc. 2016 Stock Incentive Plan. The document is signed by Jeff Craig, General Counsel and Corporate Secretary.
NeueHealth, Inc. filed post-effective amendments to two Registration Statements on Form S-8 to register shares for employee equity awards. The filings cover 2,275,000 shares registered on May 16, 2024 under the NeueHealth Second Amended and Restated 2021 Omnibus Incentive Plan and earlier registrations that together cover up to 42,000,000 and 72,285,567 shares for awards under the 2021 Incentive Plan and a prior 2016 plan. The disclosure is a routine administrative update enabling delivery of common stock for equity awards.
NeueHealth filed a Form S-8 post-effective amendment registering shares for equity award plans. The filing records registration of 2,275,000 shares for awards under the NeueHealth Second Amended and Restated 2021 Omnibus Incentive Plan. It also references prior S-8 registrations covering 42,000,000 shares for the 2021 Incentive Plan and 72,285,567 shares for the 2016 Stock Incentive Plan.
NeueHealth, Inc. submitted a Form 25 notification relating to the removal of its securities from listing and/or registration on the New York Stock Exchange LLC. The filing identifies the issuer's principal office in Minneapolis, MN and states the Exchange and the Issuer have complied with the procedural requirements under 17 CFR 240.12d2-2 for striking the class of securities from listing and/or for voluntary withdrawal. No financial results, transaction details, or dates of effectiveness are provided in the text supplied.
NeueHealth, Inc. entered into a merger under which NH Holdings 2025, Inc. (Parent) and its Merger Sub completed a merger on October 2, 2025, making the company a wholly owned subsidiary of Parent. Each outstanding share of common stock was converted into the right to receive $7.33 per share in cash, subject to withholding, while shares held by certain rollover holders were contributed to an Ultimate Parent in exchange for limited partnership interests. Options with exercise prices below $7.33 were cashed out for the spread; options with exercise prices at or above $7.33 were canceled without consideration. Service-based RSUs were assumed and converted into Parent RSUs; performance-based RSUs were canceled. The company requested NYSE suspension and delisting and submission of Form 25 to deregister its common stock.
NeueHealth, Inc. reported that the outside deadline to complete its previously announced merger has been extended. Under the existing Merger Agreement with NH Holdings 2025, Inc. and NH Holdings Acquisition 2025, Inc., the "Outside Date" has been moved to December 23, 2025, following written notice from the merger parent entity on September 18, 2025. This change gives the parties more time under the current agreement framework to work toward closing the transaction.